BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19211827)

  • 1. Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis.
    Arendt BM; Mohammed SS; Aghdassi E; Prayitno NR; Ma DW; Nguyen A; Guindi M; Sherman M; Heathcote EJ; Allard JP
    J Nutr; 2009 Apr; 139(4):691-5. PubMed ID: 19211827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis.
    Kitase A; Hino K; Furutani T; Okuda M; Gondo T; Hidaka I; Hara Y; Yamaguchi Y; Okita K
    J Gastroenterol; 2005 Jun; 40(6):617-24. PubMed ID: 16007396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
    Arendt BM; Mohammed SS; Ma DW; Aghdassi E; Salit IE; Wong DK; Guindi M; Sherman M; Heathcote EJ; Allard JP
    Curr HIV Res; 2011 Mar; 9(2):128-35. PubMed ID: 21434863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
    Hui JM; Kench J; Farrell GC; Lin R; Samarasinghe D; Liddle C; Byth K; George J
    J Gastroenterol Hepatol; 2002 Aug; 17(8):873-81. PubMed ID: 12164963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
    Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
    J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood oxidative stress markers are unreliable markers of hepatic steatosis.
    Bonnefont-Rousselot D; Ratziu V; Giral P; Charlotte F; Beucler I; Poynard T;
    Aliment Pharmacol Ther; 2006 Jan; 23(1):91-8. PubMed ID: 16393285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidative stress in the pathogenesis of chronic hepatitis C (CHC).
    Fierbinţeanu-Braticevici C; Mohora M; Creţoiu D; Creţoiu S; Petrişor A; Usvat R; Ion DA
    Rom J Morphol Embryol; 2009; 50(3):407-12. PubMed ID: 19690766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection.
    Li JF; Qu F; Zheng SJ; Wu HL; Liu M; Liu S; Ren Y; Ren F; Chen Y; Duan ZP; Zhang JL
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1725-32. PubMed ID: 24810965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
    Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
    Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
    Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
    Tillmann HL; Patel K; Muir AJ; Guy CD; Li JH; Lao XQ; Thompson A; Clark PJ; Gardner SD; McHutchison JG; McCarthy JJ
    J Hepatol; 2011 Dec; 55(6):1195-200. PubMed ID: 21703198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
    Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus.
    Fierbinţeanu-Braticevici C; Mohora M; Tribus L; Petrişor A; Creţoiu SM; Creţoiu D; Usvat R; Ioniţă L
    Rom J Morphol Embryol; 2010; 51(2):235-42. PubMed ID: 20495737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection and liver steatosis.
    Ramalho F
    Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.